Onset of action of lorazepam
Pro Research Analysisby 
Searched over 200M research papers
Onset of Action of Lorazepam: Pharmacokinetics and Clinical Effects
Intravenous Lorazepam: Slow Onset Compared to Other Benzodiazepines
When lorazepam is given intravenously, its onset of action is relatively slow compared to other benzodiazepines like diazepam. Studies show that the peak sedative and neurobehavioral effects of IV lorazepam are typically reached about 30 to 40 minutes after administration, rather than immediately. This slower onset is likely due to the drug’s delayed entry into the brain, as confirmed by both human and animal studies. In contrast, diazepam’s effects begin almost immediately after IV injection, while lorazepam’s effects build up more gradually but last longer 2346789.
Oral and Sublingual Lorazepam: Time to Peak Effect
For oral administration, lorazepam generally reaches its peak plasma concentration in about 90 to 120 minutes. However, the onset of noticeable clinical effects, such as sedation, can occur earlier, though the full effect takes longer to develop. Sublingual formulations, such as Ativan sublingual tablets, may provide a slightly faster onset than oral tablets, but still require a significant amount of time to reach full effect if intravenous or intramuscular routes are avoided 14.
Amnesic and Sedative Effects: Timing and Duration
The amnesic (anti-recall) action of lorazepam also has a delayed onset. For example, a 2 mg IV dose produces amnesia with a latency of about 30 minutes, while a 4 mg dose can shorten this latency to 15 minutes. The amnesic effect can last for several hours, with studies showing persistence up to 4 hours after administration. This is in contrast to other benzodiazepines, where amnesia can begin within 2 minutes of IV injection but typically does not last as long 56789.
Novel and Rapid-Acting Formulations
Recent research into micronized and rapidly dissolving formulations of lorazepam aims to shorten the time to peak plasma concentration and provide a faster onset of action. For example, "rapimelt" tablets and advanced sublingual or intranasal formulations are being developed to disperse quickly and improve bioavailability, with some dispersing in as little as 30 seconds in laboratory tests. These new formulations hold promise for more rapid relief in acute situations, though clinical data on their onset in humans is still emerging 110.
Conclusion
Lorazepam’s onset of action depends on the route and formulation. Intravenous lorazepam has a relatively slow onset, with peak effects at 30–40 minutes, while oral and sublingual forms take even longer to reach maximum effect. Newer, rapidly dissolving formulations may offer faster onset in the future. Overall, lorazepam is valued for its long duration of action and reliable sedative and amnesic effects, despite its slower onset compared to some other benzodiazepines 12345678+2 MORE.
Sources and full results
Most relevant research papers on this topic